Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)

Clinical trial NCT05174065 · COMPLETED

Trial details

NCT number: NCT05174065
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Palmoplantar Pustulosis

Start date: 2022-03-08
Primary completion: 2023-08-19
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.